We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Three drugmakers urged the U.S. Supreme Court not to review a lower court’s decision on the controversial patent deal between Allergan and the St. Regis Mohawk tribe. Read More
Pennsylvania’s auditor general is pushing for new state and federal legislation to increase oversight of pharmacy benefit managers and allow only flat fee rebates. Read More
Outcomes-based contracting may not help reduce drug prices, one witness cautioned lawmakers in a House Ways and Means subcommittee hearing on Thursday. Read More
An FDA advisory committee voted narrowly on Thursday against the effectiveness of Sanofi’s dengue virus vaccine and split evenly on its safety, except for children aged nine to 16. Read More
The FDA has decided not to require four-letter suffixes for already-approved or licensed biological products with no FDA-designated suffix in their proper names. Read More
The agency said it will not include substances on the list “unless the nomination identifies a drug product that must be produced from the bulk drug substance rather than from an FDA-approved drug product.” Read More